Annual Retained Earnings
-$2.11 B
-$526.24 M-33.18%
December 31, 2023
Summary
- As of February 24, 2025, CYTK annual retained earnings is -$2.11 billion, with the most recent change of -$526.24 million (-33.18%) on December 31, 2023.
- During the last 3 years, CYTK annual retained earnings has fallen by -$1.12 billion (-112.86%).
- CYTK annual retained earnings is now -9314.92% below its all-time high of -$22.43 million, reached on December 31, 2000.
Performance
CYTK Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$2.55 B
-$160.54 M-6.71%
September 30, 2024
Summary
- As of February 24, 2025, CYTK quarterly retained earnings is -$2.55 billion, with the most recent change of -$160.54 million (-6.71%) on September 30, 2024.
- Over the past year, CYTK quarterly retained earnings has stayed the same.
- CYTK quarterly retained earnings is now -2612.49% below its all-time high of -$94.07 million, reached on December 31, 2003.
Performance
CYTK Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
CYTK Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.2% | 0.0% |
| 3 y3 years | -112.9% | -98.3% |
| 5 y5 years | -184.2% | -157.2% |
CYTK Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -74.9% | at low | -111.3% | at low |
| 5 y | 5-year | -144.2% | at low | -195.0% | at low |
| alltime | all time | -9314.9% | at low | -2612.5% | at low |
Cytokinetics Incorporated Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$2.55 B(+6.7%) |
| Jun 2024 | - | -$2.39 B(+6.4%) |
| Mar 2024 | - | -$2.25 B(+6.4%) |
| Dec 2023 | -$2.11 B(+33.2%) | -$2.11 B(+6.9%) |
| Sep 2023 | - | -$1.98 B(+7.0%) |
| Jun 2023 | - | -$1.85 B(+7.5%) |
| Mar 2023 | - | -$1.72 B(+8.3%) |
| Dec 2022 | -$1.59 B(+31.3%) | -$1.59 B(+9.5%) |
| Sep 2022 | - | -$1.45 B(+10.9%) |
| Jun 2022 | - | -$1.31 B(+1.5%) |
| Mar 2022 | - | -$1.29 B(+6.5%) |
| Dec 2021 | -$1.21 B(+21.7%) | -$1.21 B(+2.6%) |
| Sep 2021 | - | -$1.18 B(+6.9%) |
| Jun 2021 | - | -$1.10 B(+5.9%) |
| Mar 2021 | - | -$1.04 B(+4.7%) |
| Dec 2020 | -$992.31 M(+14.7%) | -$992.31 M(+4.6%) |
| Sep 2020 | - | -$948.38 M(+0.3%) |
| Jun 2020 | - | -$945.20 M(+4.5%) |
| Mar 2020 | - | -$904.42 M(+4.6%) |
| Dec 2019 | -$865.02 M(+16.4%) | -$865.02 M(+3.7%) |
| Sep 2019 | - | -$834.38 M(+3.7%) |
| Jun 2019 | - | -$804.80 M(+4.2%) |
| Mar 2019 | - | -$772.69 M(+4.0%) |
| Dec 2018 | -$743.32 M(+15.1%) | -$743.32 M(+4.0%) |
| Sep 2018 | - | -$714.40 M(+3.8%) |
| Jun 2018 | - | -$688.22 M(+4.5%) |
| Mar 2018 | - | -$658.35 M(+1.9%) |
| Dec 2017 | -$646.08 M(+24.7%) | -$646.08 M(+6.7%) |
| Sep 2017 | - | -$605.60 M(+5.6%) |
| Jun 2017 | - | -$573.24 M(+5.3%) |
| Mar 2017 | - | -$544.16 M(+5.0%) |
| Dec 2016 | -$518.29 M(-3.1%) | -$518.29 M(-1.6%) |
| Sep 2016 | - | -$526.92 M(-5.7%) |
| Jun 2016 | - | -$558.81 M(+2.1%) |
| Mar 2016 | - | -$547.20 M(+2.3%) |
| Dec 2015 | -$534.74 M(+7.5%) | -$534.74 M(+1.8%) |
| Sep 2015 | - | -$525.51 M(+1.7%) |
| Jun 2015 | - | -$516.67 M(+2.1%) |
| Mar 2015 | - | -$506.12 M(+1.8%) |
| Dec 2014 | -$497.24 M(+3.0%) | -$497.24 M(-1.7%) |
| Sep 2014 | - | -$505.69 M(+1.2%) |
| Jun 2014 | - | -$499.71 M(+1.7%) |
| Mar 2014 | - | -$491.34 M(+1.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | -$482.60 M(+7.5%) | -$482.60 M(-1.3%) |
| Sep 2013 | - | -$489.13 M(+2.6%) |
| Jun 2013 | - | -$476.54 M(+3.3%) |
| Mar 2013 | - | -$461.50 M(+2.8%) |
| Dec 2012 | -$448.88 M(+9.9%) | -$448.88 M(+2.6%) |
| Sep 2012 | - | -$437.42 M(+2.4%) |
| Jun 2012 | - | -$427.38 M(+2.1%) |
| Mar 2012 | - | -$418.44 M(+2.4%) |
| Dec 2011 | -$408.51 M(+13.3%) | -$408.51 M(+3.0%) |
| Sep 2011 | - | -$396.63 M(+2.8%) |
| Jun 2011 | - | -$385.99 M(+3.7%) |
| Mar 2011 | - | -$372.36 M(+3.2%) |
| Dec 2010 | -$360.65 M(+15.8%) | -$360.65 M(+3.3%) |
| Sep 2010 | - | -$349.04 M(+3.7%) |
| Jun 2010 | - | -$336.70 M(+4.1%) |
| Mar 2010 | - | -$323.55 M(+3.9%) |
| Dec 2009 | -$311.36 M(-7.3%) | -$311.36 M(+4.2%) |
| Sep 2009 | - | -$298.83 M(+2.8%) |
| Jun 2009 | - | -$290.63 M(-16.1%) |
| Mar 2009 | - | -$346.59 M(+3.2%) |
| Dec 2008 | -$335.91 M(+20.2%) | -$335.91 M(+3.3%) |
| Sep 2008 | - | -$325.05 M(+5.3%) |
| Jun 2008 | - | -$308.79 M(+5.2%) |
| Mar 2008 | - | -$293.43 M(+5.0%) |
| Dec 2007 | -$279.53 M(+21.2%) | -$279.53 M(+5.0%) |
| Sep 2007 | - | -$266.28 M(+4.4%) |
| Jun 2007 | - | -$254.96 M(+5.2%) |
| Mar 2007 | - | -$242.33 M(+5.1%) |
| Dec 2006 | -$230.64 M(+32.9%) | -$230.64 M(+7.4%) |
| Sep 2006 | - | -$214.69 M(+7.5%) |
| Jun 2006 | - | -$199.77 M(+7.4%) |
| Mar 2006 | - | -$185.99 M(+7.2%) |
| Dec 2005 | -$173.52 M(+32.2%) | -$173.52 M(+6.8%) |
| Sep 2005 | - | -$162.44 M(+6.6%) |
| Jun 2005 | - | -$152.34 M(+7.4%) |
| Mar 2005 | - | -$141.80 M(+8.0%) |
| Dec 2004 | -$131.27 M(+39.5%) | -$131.27 M(+9.9%) |
| Sep 2004 | - | -$119.45 M(+9.4%) |
| Jun 2004 | - | -$109.24 M(+9.2%) |
| Mar 2004 | - | -$100.01 M(+6.3%) |
| Dec 2003 | -$94.07 M(+53.2%) | -$94.07 M |
| Dec 2002 | -$61.39 M(+60.2%) | - |
| Dec 2001 | -$38.31 M(+70.8%) | - |
| Dec 2000 | -$22.43 M | - |
FAQ
- What is Cytokinetics Incorporated annual retained earnings?
- What is the all time high annual retained earnings for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual retained earnings year-on-year change?
- What is Cytokinetics Incorporated quarterly retained earnings?
- What is the all time high quarterly retained earnings for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly retained earnings year-on-year change?
What is Cytokinetics Incorporated annual retained earnings?
The current annual retained earnings of CYTK is -$2.11 B
What is the all time high annual retained earnings for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual retained earnings is -$22.43 M
What is Cytokinetics Incorporated annual retained earnings year-on-year change?
Over the past year, CYTK annual retained earnings has changed by -$526.24 M (-33.18%)
What is Cytokinetics Incorporated quarterly retained earnings?
The current quarterly retained earnings of CYTK is -$2.55 B
What is the all time high quarterly retained earnings for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly retained earnings is -$94.07 M
What is Cytokinetics Incorporated quarterly retained earnings year-on-year change?
Over the past year, CYTK quarterly retained earnings has changed by $0.00 (0.00%)